IBDEI2IF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,40077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40077,1,3,0)
 ;;=3^Gout,Unspec
 ;;^UTILITY(U,$J,358.3,40077,1,4,0)
 ;;=4^M10.9
 ;;^UTILITY(U,$J,358.3,40077,2)
 ;;=^5010404
 ;;^UTILITY(U,$J,358.3,40078,0)
 ;;=G90.59^^152^2006^35
 ;;^UTILITY(U,$J,358.3,40078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40078,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,40078,1,4,0)
 ;;=4^G90.59
 ;;^UTILITY(U,$J,358.3,40078,2)
 ;;=^5004171
 ;;^UTILITY(U,$J,358.3,40079,0)
 ;;=G56.01^^152^2006^13
 ;;^UTILITY(U,$J,358.3,40079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40079,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,40079,1,4,0)
 ;;=4^G56.01
 ;;^UTILITY(U,$J,358.3,40079,2)
 ;;=^5004018
 ;;^UTILITY(U,$J,358.3,40080,0)
 ;;=G56.02^^152^2006^12
 ;;^UTILITY(U,$J,358.3,40080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40080,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,40080,1,4,0)
 ;;=4^G56.02
 ;;^UTILITY(U,$J,358.3,40080,2)
 ;;=^5004019
 ;;^UTILITY(U,$J,358.3,40081,0)
 ;;=G56.21^^152^2006^60
 ;;^UTILITY(U,$J,358.3,40081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40081,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,40081,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,40081,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,40082,0)
 ;;=G56.22^^152^2006^59
 ;;^UTILITY(U,$J,358.3,40082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40082,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,40082,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,40082,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,40083,0)
 ;;=L40.52^^152^2006^143
 ;;^UTILITY(U,$J,358.3,40083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40083,1,3,0)
 ;;=3^Psoriatic Arthritis Mutilans
 ;;^UTILITY(U,$J,358.3,40083,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,40083,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,40084,0)
 ;;=L40.53^^152^2006^144
 ;;^UTILITY(U,$J,358.3,40084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40084,1,3,0)
 ;;=3^Psoriatic Spondylitis
 ;;^UTILITY(U,$J,358.3,40084,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,40084,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,40085,0)
 ;;=M32.9^^152^2006^187
 ;;^UTILITY(U,$J,358.3,40085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40085,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,40085,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,40085,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,40086,0)
 ;;=M32.0^^152^2006^183
 ;;^UTILITY(U,$J,358.3,40086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40086,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
 ;;^UTILITY(U,$J,358.3,40086,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,40086,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,40087,0)
 ;;=M32.13^^152^2006^185
 ;;^UTILITY(U,$J,358.3,40087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40087,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
 ;;^UTILITY(U,$J,358.3,40087,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,40087,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,40088,0)
 ;;=M32.14^^152^2006^184
 ;;^UTILITY(U,$J,358.3,40088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,40088,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Glomerular Disease
 ;;^UTILITY(U,$J,358.3,40088,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,40088,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,40089,0)
 ;;=M32.12^^152^2006^186
 ;;^UTILITY(U,$J,358.3,40089,1,0)
 ;;=^358.31IA^4^2
